KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Net Cash Flow (QoQ) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1,115.57%
Dec 31, 2025 50.48%
Sep 30, 2025 -165.77%
Jun 30, 2025 452.51%
Mar 31, 2025 78.78%
Dec 31, 2024 71.31%
Sep 30, 2024 -19.34%
Jun 30, 2024 -193.49%
Mar 31, 2024 1,162.70%
Dec 31, 2023 -110.92%
Sep 30, 2023 120.80%
Jun 30, 2023 182.39%
Mar 31, 2023 5.88%
Dec 31, 2022 -178.75%
Sep 30, 2022 37.21%
Jun 30, 2022 167.20%
Mar 31, 2022 -51.79%
Dec 31, 2021 -165.49%
Sep 30, 2021 397.49%
Jun 30, 2021 -190.82%
Mar 31, 2021 155.83%
Dec 31, 2020 -71.51%
Sep 30, 2020 105.31%
Jun 30, 2020 -2,879.51%
Mar 31, 2020 -95.68%
Dec 31, 2019 432.81%
Sep 30, 2019 1,956.93%
Jun 30, 2019 111.16%
Mar 31, 2019 -234.22%
Dec 31, 2018 -115.99%
Sep 30, 2018 182.53%
Jun 30, 2018 -1,644.37%
Mar 31, 2018 -136.29%
Dec 31, 2017 886.24%
Sep 30, 2017 -134.28%
Jun 30, 2017 184.57%
Mar 31, 2017 65.19%
Dec 31, 2016 -831.03%
Sep 30, 2016 90.46%
Jun 30, 2016 -121.49%
Mar 31, 2016 28.24%
Dec 31, 2015 -141.49%
Sep 30, 2015 461.57%
Jun 30, 2015 -133.94%
Mar 31, 2015 -120.68%
Dec 31, 2014 186.61%
Sep 30, 2014 -229.06%
Jun 30, 2014 165.03%
Mar 31, 2014 -333.49%
Dec 31, 2013 181.00%
Sep 30, 2013 -87.51%
Jun 30, 2013 62.09%
Mar 31, 2013 -65.04%
Dec 31, 2012 16.26%
Sep 30, 2012 8,042.42%
Jun 30, 2012 135.71%